Alec Barclay, Chief Operations Officer at T2 Biosystems, Inc. (TTOO), sold 12,494 shares at $1.86 ($23K) on 2021-03-17, disclosed to the SEC on 2021-03-18.
Scheduled sale ($23k) by Chief Operations Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TTOO | SELL | 2020-02-25 | $5K | — | Filing → |
| TTOO | SELL | 2019-09-13 | $12K | — | Filing → |